Open AccessImpact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma
Author(s) -
HsinYu Kuo,
NaiJung Chiang,
ChiaoHsiung Chuang,
ChiungYu Chen,
IChin Wu,
TingTsung Chang,
HongMing Tsai,
YingTing Lin
Publication year - 2020
Publication title -
oncology research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000505933
Subject(s) - hepatocellular carcinoma , cancer research , tyrosine kinase , medicine , immune checkpoint , tyrosine kinase inhibitor , immune system , oncology , pharmacology , immunotherapy , immunology , cancer , receptor
The tumor microenvironments of different organs often differ and thus may affect the immunotherapy response.